Swedish Match gears up for closely watched FDA panel meeting

April 2, 2015 5:30 PM

2 0

WASHINGTON (Reuters) - In a decision that could reshape U.S. tobacco regulation, a health advisory panel will vote next week on whether Swedish Match AB, a Stockholm-based maker of smokeless tobacco products known as snus, can claim they are less harmful than cigarettes.

The closely watched vote could pave the way for the first Food and Drug Administration approval of a modified risk tobacco product and set a precedent for companies seeking to make similar claims. The two-day discussion will culminate in a vote on April 10th.

Read more

To category page

Loading...